IP Library Granted Patent US 9,481,874
Granted Patent B2
US 9,481,874 · App. 14/488,124 · Granted Nov 1, 2016

Method to improve the stability and broaden the pH range of family G/11 xylanases

Inventors: Fred Fenel (Helsinki, FI); Ossi Turunen (Vihti, FI); Matti Leisola (Espoo, FI)
C12N9/2402C12N9/2482C12Y302/01008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,481,874
App. No.
14/488,124
Granted
Nov 1, 2016
Kind
B2
Abstract

The present invention relates to protein engineering, and concerns especially family G/11 xylanases, and genes encoding said enzymes. In specific, the invention concerns Trichoderma reesei XYNII gene, which codes for endo-1,4-β-xylanase (EC 3.2.1.8). The invention describes how site-directed mutagenesis can be used to improve the properties of an enzyme to match the industrial conditions where it is used. Protein engineering can be used to improve thermoactivity and thermostability of xylanases, as well as to broaden their pH range.

Claims (7)

1. A recombinant gene encoding a variant xylanase having increased thermo stability or pH-stability when compared to a corresponding wild-type enzyme, wherein said variant comprises at least 95% sequence identity over the full length amino acid sequence of SEQ ID NO: 13, said variant having amino acid substitutions at positions corresponding to amino acids 2 and 28 of SEQ ID NO: 13.

2. The recombinant gene according to claim 1 , wherein said variant has a cysteine at positions 2 and 28.

3. The recombinant gene according to claim 2 , further comprising an arginine at amino acid position 58 and an aspartic acid residue (+191D) at the C-terminus of the enzyme.

4. The recombinant gene according to claim 3 , wherein the wild-type enzyme has the amino acid sequence of SEQ ID NO:13.

5. The recombinant gene of claim 3 , comprising SEQ ID NO:13 modified to have T2C, T28C, K58R, and +191D amino acids.

6. A recombinant gene encoding a variant xylanase having increased thermostability or pH-stability when compared to corresponding wild-type enzyme, wherein said variant comprises at least a 95% sequence identity over the full length amino acid sequence of SEQ ID NO:13, said variant further comprising an aspartic acid (+191D) at the C terminus.

7. The recombinant gene according to claim 6 , wherein said variant has an arginine at a position corresponding to position 58 of SEQ ID NO:13.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: FENEL, FRED; TURUNEN, OSSI
To: CARBOZYME OY
Reel/Frame 033929/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: CARBOZYME OY
To: GENENCOR INTERNATIONAL, INC.
Reel/Frame 033929/0470 →
CHANGE OF NAME Recorded Oct 10, 2014
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 033968/0437 →
Priority Claims (2)
FI 19992186 · Oct 12, 1999 · national
FI 20001580 · Jul 3, 2000 · national
Continuity (6)
Continuation 13849465 · Mar 22, 2013
Division 11963285 · Dec 21, 2007
Continuation 10912272 · Aug 5, 2004
Continuation 10110079
Provisional Application 60163283 · Nov 3, 1999
Related Publication 20150011743A1 · Jan 8, 2015